RG-7351: Difference between revisions
Content deleted Content added
SafariScribe (talk | contribs) m SafariScribe moved page Draft:RG-7351 to RG-7351: Publishing accepted Articles for creation submission (AFCH) |
SafariScribe (talk | contribs) Cleaning up accepted Articles for creation submission (AFCH) |
||
| Line 1: | Line 1: | ||
{{Short description|TAAR1 agonist}} |
{{Short description|TAAR1 agonist}} |
||
{{Draft topics|chemistry|medicine-and-health}} |
|||
{{AfC topic|stem}} |
|||
{{AfC submission|||ts=20241020042420|u=76.174.0.57|ns=118}} |
|||
{{AfC submission|t||ts=20241020042226|u=76.174.0.57|ns=118|demo=}}<!-- Important, do not remove this line before article has been created. --> |
|||
{{Infobox drug |
{{Infobox drug |
||
| drug_name = |
| drug_name = |
||
| Line 73: | Line 70: | ||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
{{TAAR ligands}} |
{{TAAR ligands}} |
||
{{Draft categories| |
|||
[[Category:Experimental antidepressants]] |
[[Category:Experimental antidepressants]] |
||
[[Category:TAAR1 agonists]] |
[[Category:TAAR1 agonists]] |
||
}} |
|||
{{Nervous-system-drug-stub}} |
|||
Revision as of 07:22, 20 October 2024
| Clinical data | |
|---|---|
| Other names | RG7351 |
| Drug class | Trace amine-associated receptor 1 (TAAR1) partial agonist |
RG-7351 is a trace amine-associated receptor 1 (TAAR1) partial agonist that is or was under development for the treatment of major depressive disorder.[1][2][3][4] It reached phase 1 clinical trials for this indication in 2010.[1][2][4] However, as of November 2023, no further recent development has been reported since July 2016.[1] The drug was developed by Hoffmann-La Roche.[1][2][4]
See also
- Ralmitaront (RG-7906; RO-6889450)
- Ulotaront (SEP-363856; SEP-856)
References
- ^ a b c d "RG 7351". AdisInsight. 5 November 2023. Retrieved 20 October 2024.
- ^ a b c "Delving into the Latest Updates on RG-7351 with Synapse". Synapse. 19 September 2024. Retrieved 20 October 2024.
- ^ Liu JF, Li JX (2018). "TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg". Front Pharmacol. 9: 279. doi:10.3389/fphar.2018.00279. PMC 5881156. PMID 29636691.
- ^ a b c Wu R, Liu J, Li JX (2022). "Trace amine-associated receptor 1 and drug abuse". Behavioral Pharmacology of Drug Abuse: Current Status. Adv Pharmacol. Vol. 93. pp. 373–401. doi:10.1016/bs.apha.2021.10.005. ISBN 978-0-323-91526-7. PMC 9826737. PMID 35341572.